• Boost Your Research with FREE Freezing Medium

Stem Cells

HighQC™ Human IPSC From Fibroblast-Spinal Muscular Atrophy, TYPE II

  • For research use only

Cat No.

ABC-SC2044

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Spinal Muscular Atrophy, TYPE II

Storage

Liquid Nitrogen

Cell Type: iPSC; Disease: Spinal Muscular Atrophy, TYPE II; SMA2.

Product Image

Description

HighQC™ Human IPSC From Fibroblast-Spinal Muscular Atrophy, TYPE II
is a disease-specific induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Spinal Muscular Atrophy (SMA) Type II, an autosomal recessive disorder caused by mutations in the SMN1 gene. These cells exhibit adherent growth and maintain the capacity for trilineage differentiation into ectoderm, mesoderm, and endoderm derivatives under appropriate conditions. These iPSCs (induced pluripotent stem cells) express the core pluripotency marker SSEA-4. They preserve SMA-related physiology and enable motor neuron function study. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

HighQC™ Human IPSC From Fibroblast-Spinal Muscular Atrophy Type II, HighQC™ hiPSC SMA2, hiPSC-SMAII, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Spinal Muscular Atrophy Type II

Species

Human

Cat.No

ABC-SC2044

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Spinal Muscular Atrophy, TYPE II

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Gene Info

Gene: SMN1; Mutation: EX7-8DEL

Application

  • HighQC™ Human IPSC From Fibroblast-Spinal Muscular Atrophy, TYPE II provides a patient-specific model for in vitro developmental and disease studies. Its pluripotent capacity enables directed differentiation into motor neurons, the primary cell type affected in SMA, allowing for investigation into SMN1 gene-related pathology, motor neuron development, and disease mechanisms. This system is valuable for constructing neural organoid models to study motor circuit dysfunction and for screening potential therapeutic compounds targeting neuroprotection or SMN protein restoration.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From Fibroblast-Spinal Muscular Atrophy, TYPE II

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button